Pharmalot... Pharmalittle... Good Morning

Welcome to the working week. We hope the weekend was relaxing and fruitful. Now, of course, the time has come to resume the routine of meetings and deadlines. Doing so under rainy skies does this make this a challenge, though, yes? So reach for that cup of stimulation - our flavor today is chocolate raspberry truffle - to lift your spirits. Meanwhile, here are some tidbits to help you along. Have a good day, everyone, and stay in touch...

Novartis Wins EU Approval For Gilenya MS Pill (Reuters)

FDA Not Ready To Act On Tainted Wipes (MSNBC)

Glaxo CEO Says Drugmakers Should Not Leave UK Over Taxes (The Guardian)

Xenoport Ends Development Of Heart Drug (Reuters)

Mylan Sues FDA Over Ranbaxy Lipitor Generic (Bloomberg News)

FDA And EMA Form QBD Pilot Plan (Outsourcing Pharma)

Inovio Receives DNA Vaccine Delivery Grant (InPharma Technologist)

European Regulators Reject Expanded Use For Amgen's Vectibix (CNBC)

EDITOR'S NOTE: We frequently update Pharmalittle, so check back for additional headlines